A Replication Study of the Association between Rheumatoid Arthritis and Deletion of the Late Cornified Envelope Genes LCE3B and LCE3C by Bergboer, Judith G. M. et al.
A Replication Study of the Association between
Rheumatoid Arthritis and Deletion of the Late Cornified
Envelope Genes LCE3B and LCE3C
Judith G. M. Bergboer
1, Mas ˇa Umic ´evic ´-Mirkov
2, Jaap Fransen
3, Martin den Heijer
4, Barbara Franke
2,
Piet L. C. M. van Riel
3, Joost Schalkwijk
1, Marieke J. H. Coenen
2*, on behalf of the Nijmegen Biomedical
Study principal investigators
"
1Department of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands, 2Department of
Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 3Department of Rheumatology, Radboud University Nijmegen Medical
Centre, Nijmegen, The Netherlands, 4Department of Endocrinology and Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Centre,
Nijmegen, The Netherlands
Abstract
Objective: Two recent studies, in a Spanish and a Chinese population, point to an association between rheumatoid arthritis
(RA) risk and the deletion of the Late Cornified Envelope (LCE) 3B and 3C genes (LCE3C_LCE3B-del), a known risk factor for
psoriasis. We aimed to replicate these studies in a large Dutch cohort.
Methods: 1039 RA cases and 759 controls were genotyped for LCE3C_LCE3B-del. Association analysis was performed for the
complete cohort and after stratification for the serologic markers anti-cyclic citrullinated peptide and rheumatoid factor. A
meta-analysis was performed combining our data with the Spanish and Chinese datasets, resulting in an analysis including
2466 RA cases and 2438 controls.
Results: In the Dutch cohort we did not observe a significant association of LCE3C_LCE3B-del (p=0.093) with RA risk. A
stratified analysis for the serologic positive and negative group did not show an association between the genetic variant
and disease risk, either. The meta-analysis, however, confirmed a significant association (p,0.0001, OR=1.31, 95%
confidence interval 1.16–1.47).
Conclusion: Our meta-analysis confirms the association of the LCE3 deletion with RA, suggesting that LCE3C_LCE3B-del is a
common risk factor for (auto)immune diseases.
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Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory joint
disease affecting approximately 1% of the population. Although
the causes of the disease are largely unknown, both genetic and
environmental factors seem to contribute. Thus far, genome-wide
association studies have revealed more than 30 risk loci explaining
16% of the disease variance.
The copy number of DNA segments in the human genome
varies in normal individuals and most likely this diversity is
responsible for a significant proportion of phenotypic variation.
Not much is known about the role of copy number variation
(CNV) in the etiology of RA, but relevance of these common
genetic variants is expected. A small number of candidate gene
studies have indicated that CNVs in Chemokine ligand 3-like 1
(CCL3L1), Fc gamma receptor 3B (FCGR3B) and pre-B lympho-
cyte 1 (VPREB1) are associated with RA disease susceptibility
[1,2,3]. Using a genome-wide approach the Welcome Trust Case
Control Consortium (WTCCC) reported that CNVs in the HLA
region are significantly associated with the development of RA [4].
More recently using the WTCCC dataset, 11 rare copy number
variable regions associated with RA were identified [5]. These
regions included genes that could be directly linked to the
development of RA. Another potential candidate CNV is the
deletion of two genes of the Late Cornified Envelope gene cluster,
LCE3B and LCE3C (LCE3C_LCE3B-del), which was recently
found associated with psoriasis in several populations [6], as was
rs4112788, a single nucleotide polymorphism (SNP) in high
linkage disequilibrium with the deletion [7]. The observation that
the risk of RA is increased in the offspring of individuals affected
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32045with other autoimmune disorders, including psoriasis, prompted
Docampo and colleagues [8] to investigate the association between
the LCE3C_LCE3B-del and RA in two independent Spanish
cohorts. In their study an association was found between RA and
homozygosity for LCE3C_LCE3B-del. Recently it has been
demonstrated that the deletion is also associated with RA
susceptibility in a non-Caucasian (Chinese-Han) population [9].
However, they were unable to confirm the Spanish results that the
association between LCE3C_LCE3B-del and RA risk was restricted
to anti-CCP-positive patients. We sought to replicate these studies
in a similarly powered Dutch cohort. A total of 1039 RA cases and
759 controls were genotyped for LCE3C_LCE3B-del, and we
investigated whether this genetic variant is associated with RA.
Additionally, we combined the Spanish, Chinese and Dutch data
in a meta-analysis.
Results
An overview of the demographics of the patients and controls
used in this study are presented in Table 1. Table 2 provides the
results of the association analysis for the LCE3C_LCE3B-del and
RA risk in the Dutch cohort. There were 1039 RA patients and
779 controls successfully genotyped for LCE3C_LCE3B-del. The
LCE3C_LCE3B-del and the linked SNP rs4112788 were in near-
perfect linkage disequilibrium (LD) with each other (r
2=0.928 and
D9=0.984), confirming that LCE3C_LCE3B-del was genotyped
accurately.
In the Dutch cohort, we did not find evidence for an association
between LCE3C_LCE3B-del and RA, at the genotypic (p=0.093,
OR 1.18, 95% confidence interval (95%CI): 0.97–1.43 (Table 2))
nor the allelic level (p=0.147, OR 1.11 95%CI: 0.97–1.27 (data
not shown)). It has been hypothesized that the LCE3C_LCE3B-del
might result in a defective skin barrier repair leading to an
abnormal or increased exposure to environmental antigens. This
could lead to an earlier age of disease onset in carriers of
LCE3C_LCE3B-del compared to non-carriers. An analysis for age
of onset, however, did not show association with the LCE3C_L-
CE3B-del status (p=0.25, t-test).
Docampo et al. [8] demonstrated that LCE3C_LCE3B-del
showed the strongest association with RA in anti-CCP and
rheumatoid factor (RF) positive patients. In the study of Lu et al.
[9] no associations were found in the different RA subsets, these
analyses were corrected for age and gender. We performed
association analyses of the anti-CCP and RF patient subsets
separately, for those patients with information available. We did
not find an association between LCE3C_LCE3B-del and RA in any
of the subsets analyzed (Table 2).
We performed an overall meta-analysis, using a recessive logistic
regression model unadjusted for age and gender, on the combined
data from this study and the studies of Docampo et al. [8] and Lu
et al. [9] (Table 3). Despite the lack of significance of the
association in the Dutch cohort, in the meta-analysis a significant
association between LCE3C_LCE3B-del and RA was found
(p,0.0001, OR 1.31 95%CI: 1.16–1.47). Next to the overall
analysis, we performed also a meta-analysis on the anti-CCP and
RF subgroups combining the Spanish, Chinese and our data
(Table 3), unfortunately not for all patients these data were
available. In this subgroup analysis all previously found associa-
tions [8] between LCE3C_LCE3B-del and RA were significant,
with the association apparently strongest in RF positive subset of
patients (p=0.0007, OR 1.27, 95%CI: 1.11–1.45) (Table 3).
Discussion
Although a previously reported association of the LCE3C_L-
CE3B-del with RA risk did not reach significance in our Dutch
cohort, a meta-analysis combining our data and the previously
reported Spanish and Chinese data [8,9] confirmed the association
of LCE3C_LCE3B-del with RA.
Our study had a power of over 95% to find an association,
although we based this calculation on the previously found OR of
1.45. When we recalculate the power using the OR of the meta-
analysis (OR=1.31), the power of our study drops to 73%. A
study population of 1256 samples will be needed to reach 80%
power. The ORs observed in the Dutch population are in the
same direction as seen in the previous studies [8,9] and our meta-
analysis showed a statistically significant association of the deletion
with RA. This suggests that a larger population is necessary to
prove whether the deletion is associated with RA. The
contradictory findings from this study and the previous RA studies
[8,9] could also be caused by differences in the study population,
e.g. disease phenotype or ethnicity. In addition, there is a
discrepancy between the allele frequency of the deletion in the
controls from Spain (55%) and China (54%) compared to The
Netherlands (61%). This heterogeneity of LCE3C_LCE3B-del
allele frequency in control groups from different ethnic back-
grounds was already known from previous studies [6,10]. Indeed,
a recent meta-analysis confirming an association between
LCE3C_LCE3B-del and psoriatic arthritis showed that the OR of
the Spanish population was much higher than observed in an
Italian population (1.66 versus 1.23) [10].
In our meta-analysis we used a recessive model, because this
model fitted the LCE data in the psoriasis study best, based on the
Akaike Information Criteria [11] which is in line with the two
previous studies on LCE3 in patients with RA [8,9]. Although we
could not identify an association between the deletion and RA in
the Dutch cohort, addition of the data to the other studies resulted
in lower p-values than without this dataset, showing a significant
contribution of the Dutch population to the overall results. The
addition of our Dutch samples leads to a lower OR and a smaller
CI than previously reported. The other two studies may have
significantly overestimated the magnitude of the odds ratio, the so-
called winner’s curse [12]. Due to publication bias it might be
possible that some studies investigating the same subject have not
been published, this information will be important to confirm the
association between RA and the deletion as shown in this study.
In our subgroup analysis, we observed the strongest association
in the RF positive patients. Larger datasets will be necessary to
clarify whether the observed association is patient subset specific.
In contrast to the results from our meta-analysis, genome-wide
CNV analyses using the WTCCC RA dataset did not identify
Table 1. Demographics of the rheumatoid arthritis cohort.
RA patients Controls
number 1043 779
gender (% female) 693 (66.4) 422 (54.2)
age
# 55.0612.7 56.3616.8
age at disease onset
## 45.3613.3
RF positive
### 736 (77.3)
anti-CCP positive
#### 286 (63.4)
Numbers are depicted as n(%) or mean 6 standard deviation. Data available for
#686,
##717,
###952,
####451 patients. RA: rheumatoid arthritis; CCP: anti-
cyclic citrullinated peptide; RF: rheumatoid factor.
doi:10.1371/journal.pone.0032045.t001
RA Associated with LCE3C_LCE3B-del
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rare CNVs (population frequency ,5%) which excludes the
LCE3C_LCE3B-del [5]. The other study included a probe covering
the region that passed QC in their analysis (probe CNVR358.1,
chr1:150,822,234–150,856,715 (UCSC genome browser hg18)
[4]). It might be possible that the region is associated with RA in
the WTCCC dataset at lower significance level than their genome-
wide significance threshold.
Until now, LCE3C_LCE3B-del was found to be associated with
psoriasis, psoriatic arthritis and RA in several populations
[6,7,8,9,10,11,13,14], whereas no association was found for atopic
dermatitis [15]. Also in one study an association with systemic
lupus erythematosus was found [9], implying that LCE3C_LCE3B-
del may be a common risk factor for (auto)immune diseases. The
function of the LCE genes has only been studied in skin in general
[16,17] and in relation to psoriasis [18]. From these studies it is
known that the LCE proteins are likely to be incorporated in the
cornified cell envelope, which is an important structure in the
barrier function of skin. When comparing normal and psoriasis
skin, the genes of the LCE1, 2, 5 and 6 groups are mainly
expressed in normal skin, whereas the LCE3 genes are predom-
inantly expressed in psoriasis skin. Moreover, upon barrier
Table 2. No association of the LCE3C_LCE3B deletion with RA in the Dutch cohort.
Cohort
All All CCP2 All CCP+ All RF2 All RF+
LCE3C_LCE3B deletion
Patients
no del/no del 149 (14.3) 18 (10.9) 43 (15.0) 24 (11.1) 112 (15.2)
del/no del 460 (44.3) 85 (51.5) 130 (45.5) 96 (44.4) 326 (44.3)
del/del 430 (41.4) 62 (37.6) 113 (39.5) 96 (44.4) 298 (40.5)
Controls
no del/no del 118 (15.1) 118 (15.1) 118 (15.1) 118 (15.1) 118 (15.1)
del/no del 369 (47.4) 369 (47.4) 369 (47.4) 369 (47.4) 369 (47.4)
del/del 292 (37.5) 292 (37.5) 292 (37.5) 292 (37.5) 292 (37.5)
Recessive P 0.093 0.982 0.546 0.064 0.231
OR (95% CI) 1.18 (0.97–1.43) 1.00 (0.71–1.42) 1.09 (0.83–1.44) 1.33 (0.98–1.81) 1.14 (0.92–1.40)
Codominant P 0.242 0.339 0.822 0.116 0.436
OR (95% CI) 0.99 (0.75–1.30)
(del/no del)
1.51 (0.87–2.62)
(del/no del)
0.97 (0.65–1.44)
(del/no del)
1.28 (0.78–2.09)
(del/no del)
0.93 (0.69–1.26)
(del/no del)
1.17 (0.88–1.55)
(del/del)
1.39 (0.79–2.45)
(del/del)
1.06 (0.70–1.60)
(del/del)
1.62 (0.99–2.65)
(del/del)
1.08 (0.79–1.46)
(del/del)
LCE3C_LCE3B deletion: deletion of the LCE3B and LCE3C gene; del: deletion; CCP2: patients negative for anti cyclic citrullinated peptide; CCP+: patients positive for anti-
cyclic citrullinated peptide; RF2: patients negative for rheumatoid factor; RF+ patients positive for rheumatoid factor. OR: odds ratio; 95% CI: 95% confidence interval.
doi:10.1371/journal.pone.0032045.t002
Table 3. Meta-analyses of association of the LCE3C_LCE3B deletion with RA in the Spanish, Chinese and Dutch cohort.
Spain [8] China [9] Dutch Meta-analyses
n OR L95 R95 p n OR L95 R95 p n OR L95 R95 p n OR L95 R95 p
I
2 (p
value)
LCE3C_LCE3B deletion
all data 529 1.42 1.14 1.77 0.001 898 1.38 1.11 1.70 0.0031 1039 1.18 0.97 1.43 0.093 2466 1.31 1.16 1.47 ,0.0001 0%
(0.37)
CCP2 subset 112 1.29 0.86 1.93 0.227 135 1.42 0.97 2.09 0.074 165 1.00 0.71 1.42 0.982 412 1.42 0.97 2.09 0.10 0%
(0.39)
CCP+ subset 182 1.50 1.09 2.08 0.012 411 1.36 1.05 1.76 0.021 286 1.09 0.83 1.44 0.546 879 1.29 1.09 1.52 0.002 18%
(0.30)
RF2 subset 113 1.47 0.99 2.19 0.008 105 1.44 0.94 2.20 0.095 216 1.33 0.98 1.81 0.064 434 1.40 1.13 1.72 0.002 0%
(0.92)
RF+ subset 360 1.40 1.09 1.79 0.046 382 1.37 1.05 1.78 0.020 736 1.14 0.92 1.40 0.231 1478 1.27 1.11 1.45 0.0007 0%
(0.37)
Number of controls in the Spanish, Chinese and Dutch studies is 978, 681 and 779 respectively. The number of controls in the meta-analysis is 2438. LCE3C_LCE3B
deletion: deletion of the LCE3B and LCE3C gene; del: deletion; CCP2: patients negative for anti cyclic citrullinated peptide; CCP+: patients positive for anti-cyclic
citrullinated peptide; RF2: patients negative for rheumatoid factor; RF+ patients positive for rheumatoid factor. OR: odds ratio; L95: left border 95% confidence interval.
R95: right border 95% confidence interval. I
2 (p): measure for heterogeneity and p-value of the chi-square test for heterogeneity.
doi:10.1371/journal.pone.0032045.t003
RA Associated with LCE3C_LCE3B-del
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downregulated, while the expression of the LCE3 genes is
upregulated. Altogether, these data imply a role in barrier repair
for the LCE3 proteins and a role in barrier maintenance for the
other LCEs. As hypothesized by Docampo et al. [8], the absence of
LCE3B and LCE3C could compromise barrier function of the
epithelia and possibly facilitate the entrance of environmental
antigens or pathogens. Since the LCE genes are mainly expressed
in skin and oral epithelia, these would be relevant tissues that could
facilitate the entrance of antigens or pathogens, like the Epstein-
Barr virus and the cytomegalovirus, thereby triggering RA. We
reasoned that if this would be the case patients with LCE3C_L-
CE3B-del might be exposed more readily to common antigens and
therefore would have an earlier age of onset due to easy access of
pathogens/triggers through the skin. However, we did not observe
such an association between the genotype and age of RA onset.
Our meta-analysis showed that the LCE3B and LCE3C deletion
is associated with RA, though the contribution of our large Dutch
sample is small. Therefore it will be necessary to test even larger
patient cohorts to shed more light on the possible association of the
deletion in specific RA patient subsets. An interesting next step
would be to perform functional studies to unravel the mechanisms
underlying this association.
Materials and Methods
Ethics statement
The ethical committee of the Radboud University Nijmegen
Medical Centre (‘‘Commissie Mensgebonden Onderzoek (CMO)
Regio Arnhem Nijmegen’’) approved the study (CMO number
2004/014); all patients and controls gave written informed
consent.
DNA samples
All patients met the American College of Rheumatology 1987
revised criteria for RA. The patients were part of the Dutch
Rheumatoid Arthritis Monitoring registry (www.dreamregistry.nl)
(n=1039) [19,20]. The controls (n=779) were participating in the
Nijmegen Biomedical Study [21]. For cohort characteristics see
Table 1.
Genotyping
DNA was extracted from blood using salt extraction. For the
LCE3C_LCE3B-del genotyping a polymerase chain reaction was
performed as earlier described [11]. 112 samples were genotyped
in duplicate; error rate was 2.9% and assay failure rate was 0.3%.
To validate the LCE3C-LCE3B-del genotype, we also genotyped
the linked SNP rs4112788, which was performed using a
TaqmanH SNP genotyping assay (assay ID C__31910050_10)
according to manufacturer’s recommendations (Applied Biosys-
tems, Nieuwerkerk aan den IJssel, The Netherlands). Five percent
of the samples were analyzed in duplicate; all genotypes were
concordant. The assay failure rate was 2.6%.
Statistical analysis
Descriptive statistics for quantitative values are given as mean 6
standard deviation (SD). Both variants showed no deviations from
Hardy-Weinberg equilibrium for either patients or controls. Co-
dominant and recessive logistic regression models were used to
assess the genetic effect of LCE3C_LCE3B-del on RA risk, using
homozygosity for the allele without deletion as a reference
category. These models were similar to those used in the previous
studies [8,9]. The statistical analyses were performed using SPSS
software 16.0 (SPSS Inc., Chicago, IL, U.S.A.). A meta-analysis
was performed in Review Manager 5 (Review Manager (RevMan)
Version 5.0. Copenhagen: The Nordic Cochrane Centre, The
Cochrane Collaboration, 2008) using the aggregated data from
this studies, Docampo et al. [8] and Lu et al. [9]. Heterogeneity of
odds ratios (ORs) among cohorts was calculated using the Breslow-
Day method, and pooled ORs were calculated under a fixed
effects model (Mantel-Haenszel meta-analysis). A power calcula-
tion was performed using the Genetic Power Calculator [22] with
input values derived from Docampo et al. [8] (significance level
0.05, OR=1.45, allele frequency 0.62, recessive model).
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